AMRX
Price
$7.32
Change
+$0.02 (+0.27%)
Updated
May 30 closing price
Capitalization
1.87B
66 days until earnings call
EOLS
Price
$9.19
Change
-$0.15 (-1.61%)
Updated
May 30 closing price
Capitalization
846.82M
58 days until earnings call
Interact to see
Advertisement

AMRX vs EOLS

Header iconAMRX vs EOLS Comparison
Open Charts AMRX vs EOLSBanner chart's image
Amneal Pharmaceuticals
Price$7.32
Change+$0.02 (+0.27%)
Volume$1.42M
Capitalization1.87B
Evolus
Price$9.19
Change-$0.15 (-1.61%)
Volume$1.6M
Capitalization846.82M
AMRX vs EOLS Comparison Chart
Loading...
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMRX vs. EOLS commentary
Jun 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMRX is a Hold and EOLS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 02, 2025
Stock price -- (AMRX: $7.32 vs. EOLS: $9.19)
Brand notoriety: AMRX and EOLS are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: AMRX: 74% vs. EOLS: 159%
Market capitalization -- AMRX: $1.87B vs. EOLS: $846.82M
AMRX [@Pharmaceuticals: Other] is valued at $1.87B. EOLS’s [@Pharmaceuticals: Other] market capitalization is $846.82M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMRX’s FA Score shows that 1 FA rating(s) are green whileEOLS’s FA Score has 0 green FA rating(s).

  • AMRX’s FA Score: 1 green, 4 red.
  • EOLS’s FA Score: 0 green, 5 red.
According to our system of comparison, AMRX is a better buy in the long-term than EOLS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMRX’s TA Score shows that 2 TA indicator(s) are bullish while EOLS’s TA Score has 3 bullish TA indicator(s).

  • AMRX’s TA Score: 2 bullish, 4 bearish.
  • EOLS’s TA Score: 3 bullish, 3 bearish.
According to our system of comparison, EOLS is a better buy in the short-term than AMRX.

Price Growth

AMRX (@Pharmaceuticals: Other) experienced а +2.23% price change this week, while EOLS (@Pharmaceuticals: Other) price change was -5.06% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +13.55%. For the same industry, the average monthly price growth was +16.35%, and the average quarterly price growth was +77.91%.

Reported Earning Dates

AMRX is expected to report earnings on Aug 07, 2025.

EOLS is expected to report earnings on Jul 30, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+13.55% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
AMRX($1.87B) has a higher market cap than EOLS($847M). AMRX YTD gains are higher at: -7.576 vs. EOLS (-16.757). AMRX has higher annual earnings (EBITDA): 400M vs. EOLS (-41.81M). AMRX has more cash in the bank: 91.5M vs. EOLS (62.8M). EOLS has less debt than AMRX: EOLS (127M) vs AMRX (2.75B). AMRX has higher revenues than EOLS: AMRX (2.39B) vs EOLS (202M).
AMRXEOLSAMRX / EOLS
Capitalization1.87B847M221%
EBITDA400M-41.81M-957%
Gain YTD-7.576-16.75745%
P/E Ratio90.00N/A-
Revenue2.39B202M1,185%
Total Cash91.5M62.8M146%
Total Debt2.75B127M2,166%
FUNDAMENTALS RATINGS
AMRX vs EOLS: Fundamental Ratings
AMRX
EOLS
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
91
Overvalued
88
Overvalued
PROFIT vs RISK RATING
1..100
5564
SMR RATING
1..100
96100
PRICE GROWTH RATING
1..100
6190
P/E GROWTH RATING
1..100
25100
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

EOLS's Valuation (88) in the Pharmaceuticals Major industry is in the same range as AMRX (91). This means that EOLS’s stock grew similarly to AMRX’s over the last 12 months.

AMRX's Profit vs Risk Rating (55) in the Pharmaceuticals Major industry is in the same range as EOLS (64). This means that AMRX’s stock grew similarly to EOLS’s over the last 12 months.

AMRX's SMR Rating (96) in the Pharmaceuticals Major industry is in the same range as EOLS (100). This means that AMRX’s stock grew similarly to EOLS’s over the last 12 months.

AMRX's Price Growth Rating (61) in the Pharmaceuticals Major industry is in the same range as EOLS (90). This means that AMRX’s stock grew similarly to EOLS’s over the last 12 months.

AMRX's P/E Growth Rating (25) in the Pharmaceuticals Major industry is significantly better than the same rating for EOLS (100). This means that AMRX’s stock grew significantly faster than EOLS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AMRXEOLS
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
75%
Momentum
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
82%
MACD
ODDS (%)
Bearish Trend 4 days ago
69%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bearish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
82%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 7 days ago
80%
Declines
ODDS (%)
Bearish Trend 11 days ago
78%
Bearish Trend 12 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
79%
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Interact to see
Advertisement
AMRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
EOLS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PMBCX35.950.13
+0.36%
Principal MidCap C
FOBAX20.000.03
+0.15%
Tributary Balanced Instl
ALVGX10.35N/A
N/A
American Century Focused Lg Cap Val R5
SMECX8.32-0.02
-0.24%
Invesco Small Cap Equity C
FCVFX30.53-0.18
-0.59%
Fidelity Advisor Value C

AMRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMRX has been loosely correlated with PAHC. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if AMRX jumps, then PAHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMRX
1D Price
Change %
AMRX100%
+0.27%
PAHC - AMRX
44%
Loosely correlated
-0.97%
HROW - AMRX
41%
Loosely correlated
+3.35%
VTRS - AMRX
40%
Loosely correlated
-0.45%
ZTS - AMRX
38%
Loosely correlated
+0.89%
TEVA - AMRX
37%
Loosely correlated
-4.28%
More

EOLS and

Correlation & Price change

A.I.dvisor indicates that over the last year, EOLS has been loosely correlated with AMRX. These tickers have moved in lockstep 33% of the time. This A.I.-generated data suggests there is some statistical probability that if EOLS jumps, then AMRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EOLS
1D Price
Change %
EOLS100%
-1.61%
AMRX - EOLS
33%
Loosely correlated
+0.27%
ALKS - EOLS
30%
Poorly correlated
+1.19%
AQST - EOLS
30%
Poorly correlated
-2.87%
NBIX - EOLS
30%
Poorly correlated
-0.52%
AMPH - EOLS
28%
Poorly correlated
+0.27%
More